对慢性缩性胃炎治疗的分子洞察力:Coptis chinensis Franch通过网络药理学,分子动力学模拟和实验分析进行了研究
Chengxiang Hu1, Fuyan Cao1, Yongxin Jiang1
1Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education and Edmond H. Fischer Signal Transduction Laboratory, School of Life Science, Jilin University, 2699 Qianjin Street, Changchun, 130012, China.
法国Coptis chinensis (CCF) 通过向关键信号通路,有效治疗慢性缩性胃炎 (CAG). 柏柏林被确定为主要活性化合物,为管理这种消化系统疾病提供了新的见解.
科学领域:
- 传统中国医药 传统中国医药
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 慢性缩性胃炎 (CAG) 是一种常见的消化系统疾病,也是胃癌的前体.
- 法国Coptis chinensis (CCF) 具有抗炎性质,是用于CAG治疗的Zuojin Pill (ZJP) 的关键成分.
研究的目的:
- 阐明CCF在治疗CAG中的治疗机制.
- 为 CAG 管理确定 CCF 的活性化合物和分子标.
主要方法:
- 网络药理学 网络药理学
- 分子对接是分子对接.
- 模拟分子动力学模拟
- 实验验证实验验证的验证
主要成果:
- 在CCF和关键信号通路中确定了三种主要活性化合物 (例如TNF,PI3K-Akt,p53).
- 柏柏林通过分子对接,动态和实验验证被证实是CCF的主要活性化合物.
- 发现了活性化合物与PTGS2,TNF,MTOR和TP53等标之间的相互作用.
结论:
- 柏柏林是CCF中治疗CAG的主要活性化合物.
- 这项研究为CCF对CAG的疗效提供了分子洞察力.
- 为 CAG.提供了一个参考,用于开发改进的治疗策略.
更多相关视频
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
相关概念视频
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...